Skip to main content
Clinical Trials/NCT00000252
NCT00000252
Completed
Phase 2

Lack of Acute Tolerance Development to Effects of Nitrous Oxide

University of Chicago1 site in 1 country11 target enrollmentJune 1994

Overview

Phase
Phase 2
Intervention
10% N2O
Conditions
Opioid-Related Disorders
Sponsor
University of Chicago
Enrollment
11
Locations
1
Primary Endpoint
Psychomotor performance
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine the lack of acute tolerance development to the subjective, cognitive, and psychomotor effects of nitrous oxide in healthy volunteers.

Registry
clinicaltrials.gov
Start Date
June 1994
End Date
June 1996
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

10% N2O

Subjects will inhale 10% N2O

Intervention: 10% N2O

20% N2O

Subjects will inhale 20% N2O

Intervention: 20% N2O

30% N2O

Subjects will inhale 30% N2O

Intervention: 30% N2O

40% N2O

Subjects will inhale 40% N2O

Intervention: 40% N2O

0% N2O

Subjects will inhale 0% N2O

Intervention: 0% N2O

Outcomes

Primary Outcomes

Psychomotor performance

Time Frame: During inhalation

Subjects will undergo psychomotor testing during 120 min inhalation session of each intervention

Cognitive performance

Time Frame: During inhalation

Subjects will under cognitive testing during 120 minute inhalation session of each intervention

Study Sites (1)

Loading locations...

Similar Trials